Urothelium Tissue Engineering Using Biopsies From Transurethral Resection

Status Not yet recruiting

Clinical Trial Summary

Different clinical conditions can require urinary bladder augmentation or replacement. Tissue engineered bladder has been clinically evaluated but is not recommended due to diverse side effects. Thus, there is a real interest for the development of regenerative approach with innovative scaffolds and cell transplantation.

The investigators propose the use of urothelial cells obtained by Trans-Urethral Resection of Prostate or bladder (TURP) to obtain a tissue engineered urothelium in association with different scaffolds.

Clinical Trial Description

Bladder biopsies will be obtained during cystoscopy, conserved in culture medium (DMEM®), digested by dispase and sowed on collagen-coated culture support. Keratinocyte Serum Free Medium (KSFM) will be used for proliferation. Microscopy, immunohistochemistry, RNA extraction, Reverse Transcription and quantitative Polymerase Chain Reaction (RT-qPCR) will be performed during passages. Cell culture conditions will be optimized to improve proliferation and avoid loss of differentiation. The investigators will develop scaffolds based on sodium alginate hydrogels, followed by freeze-drying to generate porous sponges (at -20°C and -80°C). Cultured cells will be associated to these original scaffolds and to other scaffolds, for example alginate hydrogels or Collagen Cell Carrier (CCC), cultivated for 28 days and analyzed. Histological and immunohistological appearance of cellularized scaffolds will be compared to assess the effectiveness of each scaffold for tissue engineering in urothelium.

Cellularized scaffolds will be studied in vitro (Transepithelial Electrical Resistance, impermeability, ability to be stitched, resistance to urine) and in vivo in ectopic location (subcutaneous location in Nude mice) or in orthotopic location (bladder augmentation in small animal). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03698721
Study type	Observational
Source	Central Hospital, Nancy, France
Contact	Nicolas Berte, Dr
Phone	00333673004195
Email	n.berte@chru-nancy.fr
Status	Not yet recruiting
Phase
Start date	October 2018
Completion date	October 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06065995` - StoMakker Mobile Application	N/A
Not yet recruiting	`NCT06007885` - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention.	N/A
Completed	`NCT02854150` - Improving Genetic Counseling for Patients With Spina Bifida Using Next Generation Sequencing
Completed	`NCT00655681` - Prevention of Post Operative Bone Loss in Children	N/A
Completed	`NCT00378664` - Lumbar to Sacral Ventral Nerve Re-Routing	Phase 2
Active, not recruiting	`NCT00891891` - Psychosocial Adjustment of Adolescents With Spina Bifida
Active, not recruiting	`NCT00031122` - Study of Genetic Risk Factors for Spina Bifida and Anencephaly	N/A
Completed	`NCT03573726` - Use of a Diurnal Indwelling Urethral Catheter to Improve Quality of Life	N/A
Completed	`NCT03851107` - The Effectiveness of Participation-focused Interventions on Body Functions of Youth With Physical Disabilities	N/A
Recruiting	`NCT02938130` - The Impact of Community-based Wellness Programs on The Triple Aim	N/A
Recruiting	`NCT02592291` - Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions	N/A
Not yet recruiting	`NCT05784285` - Downstream Effects of Personalized 'Top-down' Participation-based Interventions Among Youth With Physical Disabilities	N/A
Completed	`NCT00720161` - Metformin in Children With Motor Deficit	N/A
Completed	`NCT05861024` - Urinary Calculi After Bladder Augmentation in Children
Completed	`NCT05858840` - Urinary Artificial Sphincter in Children
Recruiting	`NCT04362592` - In-Utero Endoscopic Correction of Spina Bifida	N/A
Recruiting	`NCT03856034` - Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele	N/A
Enrolling by invitation	`NCT04186130` - Fecal Microbium Change in Pediatric Patients With Spina Bifida: Prospective Case-control Study
Active, not recruiting	`NCT05117827` - Pediatric Powered Wheelchair Standing Devices: An Exploratory Study	N/A
Completed	`NCT03121651` - Medication Management Among Individuals With Neurodevelopmental Disabilities	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Urothelium Tissue Engineering Using Biopsies From Transurethral Resection of Prostate — IMOPU

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms